Catastrophic antiphospholipid syndrome: Report of 4 cases

Journal of Nephrology

Volumn 20, Issue 6, 2007, Pages 739-744

  Sinico, Renato Alberto ^a   Di Toma, Luca ^a   Sabadini, Ettore ^a   Renoldi, Piero ^a   Li Vecchi, Maurizio ^b  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Anticardiolipin antibodies; Catastrophic anti phospholipid syndrome; Lupus anticoagulant; Microangiopathic disease; Systemic lupus erythematosus

Indexed keywords

ANTICOAGULANT AGENT; ANTIMALARIAL AGENT; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEFIBROTIDE; ESTROGEN; FIBRINOLYTIC AGENT; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROSTACYCLIN; RITUXIMAB; STEROID; TEICOPLANIN; WARFARIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EARLY DIAGNOSIS; FEMALE; HEART INFARCTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LUNG VENTILATION; MALE; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; VAGINA BLEEDING;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; FATAL OUTCOME; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLASMA EXCHANGE; THROMBOSIS;

EID: 39449089444     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-12.
2. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Campos MT, Jacobson S, Lakos G, Tincani A, Kontopouli-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gramnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssian S, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez-Nebro A, Boffa MC, Hughes GR, Ingelmo M; for the Euro-Phospholipid Project Group. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-27.
3. Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: Where do we stand? Arthritis Rheum 2003; 48: 3320-7.
4. Harris EN, Pierangeli SS. Primary, secondary, catastrophic antiphospholipid syndrome: Is there a difference? Thromb Res 2004; 114: 357-61.
5. Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients. Medicine 1998; 77: 195-207.
6. Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome in 2004: A review. Autoimmun Rev 2005; 4: 48-54.
7. Levine S, Branch D, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
8. Triplett D, Ascherson RA. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol 2000; 65: 154-9.
9. Cervera R, Font J, Gomez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, Ramon Casals M, Ingelmo M, Piette SC, Shoenfeld Y, Asherson RA; for the Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1205-9.
10. Amintal H, Rubinow A, Langevitz P, Shoenfeld Y. Refractory leg infection as an inducer of the catastrophic antiphospholipid syndrome. Ann Rheum Dis 2004; 63: 1004.
11. Asherson RA, Cervera R, Piette JC, Shoenfeld Y, Espinosa G, Petri MA, Lim E, Lau TC, Gurjal A, Jedryca-Goral A, Chwalinska-Sadowska H, Dibner RJ, Rojas-Rodriguez J, Garcia-Garrasco M, Grandone JT, Parke AL, Barbosa P, Vasconcelos C, Ramon-Casals M, Font J, Ingelmo M. Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine 2001; 80: 355-77.
12. Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, Ramon-Casals M, Ingelmo M; for the Catastrophic Antiphospholipid Syndrome Registry Project Group. The acute respiratory distress syndrome: Analysis of a series of 47 patients. Ann Rheum Dis 2006; 65: 81-6.
13. Asherson RA, Espinosa G, Cervera R, Gomez-Puerta JA, Musurnama J, Bucciarelli S, Ramon-Casals M, Martinez-Gonzales AL, Ingelmo M, Recerter J, Font J, Triplett DA. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: Clinical and haematological characteristic of 23 patients. Ann Rheum Dis 2005; 64: 943-6.
14. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamshta MA, Shoenfeld Y; for the Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-4.
15. Navarrete N, Macias P, Jaen F, Hidalgo C, Caliz R, Jimenez-Alonso J. Two cases of catastrophic antiphospholipid syndrome. Lupus 2005; 14: 907-9.
16. Asherson RA, Espinosa G, Cervera R, Font J, Reverber JC. Catastrophic antiphospholipid syndrome. Proposed guidelines for diagnosis and treatment. J Clin Rheumatol 2002; 8: 157-65.
17. Erkan D. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmun Rev 2006; 6: 98-103.
18. Uthman I, Shamseddine A, Taher A. The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome. Transfus Apher Sci 2005; 33: 11-7.